Masimo Corporation $MASI Shares Purchased by Squarepoint Ops LLC

Key Points

• Squarepoint Ops LLC boosted its stake in Masimo by 738.8% in Q3, adding 546,905 shares to hold 620,932 shares (about 1.16% ownership) valued at ~$91.62 million.
• Institutional investors collectively own 85.96% of Masimo, with multiple funds (Royal Bank of Canada, AQR, Jones Financial, among others) increasing or initiating positions in recent quarters.
• MASI trades near its 52‑week high (opened at $175.49; 52‑week range $125.94–$175.90) with a $9.43B market cap and negative trailing P/E, and analysts show a consensus "Hold" rating and a $181.17 target (1 Buy, 7 Hold, 1 Sell).

Squarepoint Ops LLC boosted its holdings in shares of Masimo Corporation (NASDAQ:MASI - Free Report) by 738.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 620,932 shares of the medical equipment provider's stock after acquiring an additional 546,905 shares during the period. Squarepoint Ops LLC owned 1.16% of Masimo worth $91,619,000 at the end of the most recent reporting period.

A number of other institutional investors have also bought and sold shares of the business. Royal Bank of Canada grew its position in shares of Masimo by 44.5% in the first quarter. Royal Bank of Canada now owns 43,884 shares of the medical equipment provider's stock valued at $7,311,000 after purchasing an additional 13,513 shares in the last quarter. AQR Capital Management LLC increased its holdings in shares of Masimo by 136.5% in the first quarter. AQR Capital Management LLC now owns 8,142 shares of the medical equipment provider's stock valued at $1,305,000 after purchasing an additional 4,700 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in Masimo by 0.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,371 shares of the medical equipment provider's stock worth $1,894,000 after buying an additional 66 shares in the last quarter. Dynamic Technology Lab Private Ltd acquired a new position in Masimo during the first quarter worth $220,000. Finally, Jones Financial Companies Lllp boosted its stake in Masimo by 1,267.1% during the first quarter. Jones Financial Companies Lllp now owns 2,201 shares of the medical equipment provider's stock worth $367,000 after buying an additional 2,040 shares during the last quarter. 85.96% of the stock is owned by hedge funds and other institutional investors.

Masimo Price Performance

MASI stock opened at $175.49 on Friday. Masimo Corporation has a 52-week low of $125.94 and a 52-week high of $175.90. The company has a quick ratio of 1.47, a current ratio of 2.49 and a debt-to-equity ratio of 0.72. The stock has a market cap of $9.43 billion, a price-to-earnings ratio of -16.65, a price-to-earnings-growth ratio of 1.78 and a beta of 1.21. The business has a fifty day moving average of $151.80 and a two-hundred day moving average of $145.86.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on MASI shares. Bank of America assumed coverage on Masimo in a research note on Monday, November 17th. They issued a "neutral" rating and a $162.00 target price for the company. Wolfe Research cut shares of Masimo from a "strong-buy" rating to a "hold" rating in a research report on Thursday, February 19th. Wells Fargo & Company lowered shares of Masimo from an "overweight" rating to an "equal weight" rating and dropped their price objective for the company from $190.00 to $180.00 in a report on Wednesday, February 18th. Weiss Ratings restated a "sell (d)" rating on shares of Masimo in a research report on Thursday, January 22nd. Finally, Needham & Company LLC reaffirmed a "hold" rating on shares of Masimo in a research note on Monday, December 1st. One investment analyst has rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Hold" and a consensus target price of $181.17.

Masimo Company Profile

Masimo NASDAQ: MASI is a global medical technology company specializing in noninvasive monitoring solutions. The company's flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo's portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.

Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Corporation (NASDAQ:MASI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.